1Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure:epidemiology,mechanisms and therapeutic implications.CNS Drugs, 2001,15(8):633-642.
2Verrotti A, Greco R, Latini G,et al. Increased bone turnover in prepubertal,pubertal,and postpubertal patients receiving carbamazepine. Epilepsia, 2002,43 ( 12 ): 1488-1492.
3Onodera K, Takahashi A, Wakabayashi H, et al. Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives)in osteopenia induced by phenytoin in growing rats.Nutrition, 2003,19(5) :446-450.
4Feldkamp J, Becker A, Witte OW, et al. Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like.Cells Exp Clin Endocrinol Diabetes, 2000,108 ( 1 ) :37-43.
5Farhat G,Yamout B ,Mikati MA,et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology,2002,58(9):1348- 1353.
6Oner N, Kaya M, Karasalihoglu S,et al. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health, 2004,40 ( 8 ) :470-473.
7Kafali G,Erselcan T,Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediair, 1999,38 (2) :93-98.
8Chung S,Ahn C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev, 1994,16(5): 382-385.
9Ensrud KE,Walczak TS,Blackwell T,et al. Antiepileptic drug use increases rates of bone loss in older women:a prospective study. Neurology, 2004,62 ( 11 ) :2051-2057.
10Akin R, Okutan V, Sarici U, et al.Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol, 1998,19 (2):129-131.
